🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀 We are making strides in 𝐀𝐈-𝐩𝐨𝐰𝐞𝐫𝐞𝐝 𝐯𝐚𝐥𝐯𝐮𝐥𝐚𝐫 𝐚𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭 for echocardiography—this time, focusing on the 𝐭𝐫𝐢𝐜𝐮𝐬𝐩𝐢𝐝 𝐯𝐚𝐥𝐯𝐞. Recently presented at #ACC25, the study demonstrates the development and validation of an 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝

Honoured to be featured on The Cardiac Wire Show at #ACC25, where Us2.ai’s impact on echocardiography was given the spotlight 🎥 Our FDA-cleared AI solution automates echo analysis in under two minutes: ▶️ no clicks ▶️ no manual input ▶️ 100% reproducibility

Attending #HeartFailure2025? The Us2 team will be on the ground and available for conversations around AI, echocardiography, and innovation in heart failure care. If you’d like to connect, reach out to schedule a time—we’d love to meet you there. 📩 Book a meeting: [email protected]

🌟 Highlighting abstracts featuring Us2 at #HeartFailure2025! If you’re attending, be sure to check them out and see how AI is advancing echocardiography and heart failure care. #AIEcho #Echocardiography #AI #HeartFailure #Innovation #PatientsFirst #AIinCardiology #Cardiology

Don't miss this 𝐋𝐚𝐭𝐞 𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 presentation featuring Us2 at #HeartFailure2025 🫀 Dr Diana Foo, MD, MBA, will be presenting findings from the 𝐇𝐞𝐚𝐫𝐭2𝐌𝐢𝐬𝐬 initiative — a decentralized, community-based rapid cardiac ultrasound triage program designed for

Get a closer look at the 𝐓𝐀𝐑𝐓𝐀𝐍-𝐇𝐅 𝐭𝐫𝐢𝐚𝐥 (NCT05705869)—the Scottish participating site for 𝐒𝐘𝐌𝐏𝐇𝐎𝐍𝐘-𝐇𝐅. At #HeartFailure2025, the team will present the 𝐭𝐫𝐢𝐚𝐥 𝐝𝐞𝐬𝐢𝐠𝐧 𝐚𝐧𝐝 𝐦𝐞𝐭𝐡𝐨𝐝𝐬 of a randomised controlled trial that will assess the

🚨 Missed this Late-Breaking Science at #HeartFailure2025? Heart2Miss took the stage for its AI-supported, community-based rapid cardiac ultrasound triage program designed for early HF detection. 👩‍🔬 Trained novice bioscience grads as mobile sonographers 🏥 Enabled early HF

🌟 Investigator Spotlight: Dr. Diana Foo on Heart2Miss 🌟 𝑯𝒆𝒂𝒓𝒕2𝑴𝒊𝒔𝒔, an AI-supported cardiac ultrasound triage programme for early heart failure (HF) detection in Malaysia, was featured on the main stage at #HeartFailure2025 — recognised for its innovative,

🚀 Reimagining the Echo Workflow At Us2.ai, we’re not just building tools—we’re redefining how AI echo fits into clinical and research workflows. 🔗 Seamlessly connect with POCUS devices, echo carts, and EHR systems ⚙️ Automated processing and reporting

The AI-ECHO RCT, presented at AHA last year, identified five key advantages of integrating AI into clinical echocardiography workflows: 1️⃣ Increase in number of daily examinations 2️⃣ Reduction in echo examination time 3️⃣ Richer clinical data by providing more measurements 4️⃣

🔥  Exciting news from the Netherlands! Us2.ai is now powering AI-driven echocardiography at Erasmus MC  and WilhelminaZkhsAssen (WZA) — two leading healthcare institutions committed to innovation and patient-centered care. With growing demand for cardiovascular

🚨 Catch Us2.ai on the Road! 🚨 We’re excited to be at #ParisEcho 2025, happening 11–13 𝐉𝐮𝐧𝐞 at the 𝘗𝘢𝘭𝘢𝘪𝘴 𝘥𝘦𝘴 𝘊𝘰𝘯𝘨𝘳è𝘴, Paris 🇫🇷. Join us for 𝐥𝐢𝐯𝐞 𝐬𝐜𝐚𝐧𝐧𝐢𝐧𝐠 and get a firsthand look at our cutting-edge AI technology that’s

📊 GLS Vendor Comparison: A Decade On 10 years after the first head-to-head comparison of 2D speckle-tracking echocardiography derived GLS measurements obtained with software solutions from different vendors, the authors compared again GLS results in 3 vendor-specific & 6

🧐 𝐃𝐢𝐝 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰? Us2.ai is 𝐯𝐞𝐧𝐝𝐨𝐫 𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 — our solution is fully compatible with 𝘢𝘭𝘭 echo machines, POCUS devices, and PACS systems, no matter the manufacturer. This flexibility makes it easier than ever to bring AI-powered

📣 Big news: Us2.ai’s latest AI echo software is now CE marked for clinical use in Europe! What’s new? ✅ 𝐄𝐱𝐩𝐚𝐧𝐝𝐞𝐝 𝐂𝐄-𝐌𝐚𝐫𝐤𝐞𝐝 𝐌𝐞𝐚𝐬𝐮𝐫𝐞𝐦𝐞𝐧𝐭𝐬 𝐟𝐨𝐫 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐄𝐜𝐡𝐨 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 ✅ 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡:

🌍 𝐔𝐬2.𝐚𝐢 𝐢𝐬 𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐀𝐈 𝐞𝐜𝐡𝐨 𝐢𝐧 𝐡𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬 𝐚𝐜𝐫𝐨𝐬𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 — now with 𝐂𝐄 𝐌𝐚𝐫𝐤 𝐜𝐥𝐞𝐚𝐫𝐚𝐧𝐜𝐞 for the latest version of our fully automated software! We’re proud to share that the latest version of our AI echocardiography

🫀 AI-Powered Detection of Cardiac Amyloidosis — Now CE Marked In a first-of-its-kind capability, the software now incorporates AI-based pattern recognition to detect cardiac amyloidosis from a single apical four-chamber (A4C) view —offering clinicians a practical tool for

📊 Us2.ai Delivers Fully Automated Strain — Now CE Marked In a landmark multi-vendor comparison study, our AI GLS demonstrated results comparable to semi-automated vendor solutions! ✅ 𝐙𝐞𝐫𝐨 𝐨𝐩𝐞𝐫𝐚𝐭𝐨𝐫 𝐢𝐧𝐩𝐮𝐭 𝐫𝐞𝐪𝐮𝐢𝐫𝐞𝐝 — no manual tracing or

📍 AI Echo in Action: Integration of Us2.ai into a high-volume echo department New publication conducted in 🇫🇷 shows Us2.ai was integrated into a high-volume echo department in just 6 weeks — streamlining workflow, boosting efficiency, and

💭 What do clinicians really think about using AI in their echo workflow? A new study in #JASE by Dr. Ilya Karagodin & the Endeavour Health team shares their early experience using Us2.ai. Clinicians found AI echo to be: ✅ Accurate ✅ Helpful in